MedTrace Logo

Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section

NCT07054775 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2025-07-08

No results posted yet for this study

Summary

This study compares the incidence of pruritus (itching) requiring treatment between two doses of intrathecal morphine (0.1 mg vs 0.2 mg) when used for spinal anesthesia during cesarean section. The study aims to determine if the lower dose (0.1 mg) can reduce pruritus incidence while maintaining adequate pain relief.

Conditions

  • Pruritus Caused by Drug

Interventions

DRUG

Morphine Sulfate

intrathecal administered morphine

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Thepakorn Sathitkarnmanee · Faculty of Medicine, Khon Kaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-10-31
Completion
2025-11-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07054775 on ClinicalTrials.gov